HomePodcastsThe Long Run with Luke TimmermanEp210: Cameron Turtle on Long-Lasting Antibodies for Immune DisordersThe Long Run with Luke TimmermanEp210: Cameron Turtle on Long-Lasting Antibodies for Immune DisordersSeptember 23, 2026 · 1 h 4 minPlay episodeShare from this pointShow notesCameron Turtle, CEO of Waltham, Mass.-based Spyre Therapeutics, on developing long-lasting antibodies for immune disorders.All episodes of The Long Run with Luke Timmerman